MVCAX
Price
$31.31
Change
+$0.30 (+0.97%)
Updated
Jul 17 closing price
Net Assets
16.88B
SMVZX
Price
$12.35
Change
+$0.14 (+1.15%)
Updated
Jul 17 closing price
Net Assets
1.56B
Interact to see
Advertisement

MVCAX vs SMVZX

Header iconMVCAX vs SMVZX Comparison
Open Charts MVCAX vs SMVZXBanner chart's image
MFS Mid Cap Value A
Price$31.31
Change+$0.30 (+0.97%)
VolumeN/A
Net Assets16.88B
Virtus Ceredex Mid-Cap Value Equity R6
Price$12.35
Change+$0.14 (+1.15%)
VolumeN/A
Net Assets1.56B
MVCAX vs SMVZX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MVCAX vs. SMVZX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and SMVZX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.9B vs. SMVZX (1.56B). SMVZX pays higher dividends than MVCAX: SMVZX (1.17) vs MVCAX (0.87). MVCAX was incepted earlier than SMVZX: MVCAX (24 years) vs SMVZX (11 years). MVCAX (1.00) is less costly to investors than SMVZX (0.88). SMVZX is a more actively managed with annual turnover of: 141.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than SMVZX: MVCAX (1000) vs SMVZX (2500000). SMVZX (-5.33) and MVCAX (-5.36) have marching annual gain over last year. MVCAX return over 5 years is better than : 51.43 vs. SMVZX (23.33).
MVCAXSMVZXMVCAX / SMVZX
Total Expense Ratio0.990.79125%
Annual Report Gross Expense Ratio1.000.88114%
Fund Existence24 years11 years-
Gain YTD1.0761.16093%
Front Load6%N/A-
Min. Initial Investment100025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.9B1.56B1,081%
Annual Yield % from dividends0.871.1774%
Returns for 1 year-5.36-5.33101%
Returns for 3 years17.9523.9375%
Returns for 5 years51.4323.33220%
Returns for 10 years61.161.145,347%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHGCY23.350.40
+1.74%
Chugai Pharmaceutical Co., Ltd.
MEQYF133.54N/A
N/A
Mainstreet Equity Corp.
NBGRY13.75-0.09
-0.61%
NATIONAL BK GREECE S A
HLRTF0.07N/A
-3.11%
HILLCREST ENERGY TECHNOLOGIES LTD.
TSMCF0.08-0.01
-8.33%
TESMEC S P A